Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP-435 in combination with methotrexate in rheumatoid arthritis
NCT01143337Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jun 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing MP-435 + Methotrexate with Placebo + Methotrexate (2 arms). Primary endpoint: American College of Rheumatology 20% Response at 12 weeks. Started Jun 2010; status: completed.
02
Drugs
MP-435
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01143337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143337.